COMMODORE CAPITAL LP - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
COMMODORE CAPITAL LP ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$14,901,000
+72.9%
440,869
+19.7%
5.19%
+51.2%
Q1 2021$8,618,000
-29.4%
368,448
-13.0%
3.43%
-48.3%
Q4 2020$12,203,000423,7086.64%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP, LLC 3,034,083$37,259,00042.17%
Svennilson Peter 4,677,939$57,446,00016.42%
VHCP Management II, LLC 726,677$8,924,0002.81%
Casdin Capital, LLC 1,523,960$18,714,229,0001.75%
P.A.W. CAPITAL CORP 120,000$1,474,0001.59%
Cormorant Asset Management, LP 1,271,685$15,616,0000.90%
VHCP Management III, LLC 66,667$819,0000.38%
Orbimed Advisors 835,842$10,264,0000.16%
Hillhouse Capital Management 317,921$3,904,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,600$2,255,0000.08%
View complete list of CONSTELLATION PHARMCETICLS I shareholders